Managers

NEA leads Series A round for Reneo Pharmaceuticals

San Diego-based Reneo Pharmaceuticals, a clinical-stage pharmaceutical company, has raised $50 million in Series A financing. New Enterprise Associates led the round.

Rinri Therapeutics lands seed funding

UK-based Rinri Therapeutics, a biotech company, has secured 1.4 million pounds in seed funding. Boehringer Ingelheim Venture Fund and UCB Ventures led the round with participation from BioCity.

DCM’s Kyle Lui on cannabis investing and the ballooning market opportunity

Bond seeks $1.25 bln, Fuel reloads with $75 mln and a recap of more recent venture fundraising activities

HLM Venture Partners targets $125 mln for fifth fund

HLM Venture Partners is seeking to raise $125 million for its fifth fund, according to an SEC filing. The Boston-based venture firm invests in healthcare.

HLM Venture Partners targets $125 mln for fifth fund

HLM Venture Partners is seeking to raise $125 million for its fifth fund, according to an SEC filing. The Boston-based venture firm invests in healthcare.

Health at Scale picks up $16 mln Series A

Health at Scale, a provider of machine intelligence for health care optimization, has secured $16 million in Series A funding. The investors were not named.

Actuate Therapeutics inks $21.7 mln Series B

Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.

Actuate Therapeutics inks $21.7 mln Series B

Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.

CEO-founded Pillar wraps up Fund II at $100 mln